{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:52:56Z","timestamp":1768546376052,"version":"3.49.0"},"reference-count":59,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001250","name":"Purdue University and Morris Animal Foundation","doi-asserted-by":"publisher","award":["D24FE-608"],"award-info":[{"award-number":["D24FE-608"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Weight loss occurs with chronic kidney disease (CKD) and is present in the early stages. Growth differentiation factor 8 (GDF8), also known as myostatin, is a negative regulator of muscle growth, and circulating GDF8 concentrations are increased in people with CKD. The objective of this study was to evaluate if serum GDF8 concentrations in cats with early CKD are increased compared to healthy cats. Associations of GDF8 with age, sex, body weight, body condition score (BCS), muscle condition score (MCS), and selected renal parameters were also examined. Serum GDF8 in healthy (n = 10), International Renal Interest Society (IRIS) stage 1 CKD (n = 5), and IRIS stage 2 CKD (n = 10) cats was quantified using a commercially available sandwich ELISA. GDF8 was not different amongst healthy cats (2137 \u00b1 740 pg\/mL) and cats with IRIS stage 1 (1785 \u00b1 530 pg\/mL) and IRIS stage 2 (1961 \u00b1 638 pg\/mL; p = 0.608) CKD. GDF8 was moderately correlated with MCS (rs = 0.517, 95% CI 0.006\u20130.814, p = 0.049) and inversely correlated with age (r = \u22120.429, 95% CI \u22120.705 to \u22120.041, p = 0.032), but no association was found with the selected renal parameters, body weight, or BCS.<\/jats:p>","DOI":"10.3390\/vetsci13010089","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:31:41Z","timestamp":1768480301000},"page":"89","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Growth Differentiation Factor 8 (Myostatin) Concentrations in Cats with Early-Stage Chronic Kidney Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Kerrigan","family":"Fleming","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-2684","authenticated-orcid":false,"given":"William H.","family":"Whitehouse","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/jcsm.13260","article-title":"Kidney function in cachexia and sarcopenia: Facts and numbers","volume":"14","author":"Okamura","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","article-title":"Myostatin and muscle atrophy during chronic kidney disease","volume":"36","author":"Bataille","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/jvim.14561","article-title":"Evaluation of Weight Loss Over Time in Cats with Chronic Kidney Disease","volume":"30","author":"Freeman","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.ajkd.2007.02.277","article-title":"Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis","volume":"49","author":"Kovesdy","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.jrn.2020.05.007","article-title":"Muscle Mass Assessed by Computed Tomography at the Third Lumbar Vertebra Predicts Patient Survival in Chronic Kidney Disease","volume":"31","author":"Bichels","year":"2021","journal-title":"J. Ren. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1939-1676.2011.00805.x","article-title":"Association between body condition and survival in dogs with acquired chronic kidney disease","volume":"25","author":"Parker","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1939-1676.2007.tb03042.x","article-title":"Prognostic Factors in Cats with Chronic Kidney Disease","volume":"21","author":"King","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gr.7.9.910","article-title":"Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle","volume":"7","author":"Kambadur","year":"1997","journal-title":"Genome Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mosher, D.S., Quignon, P., Bustamante, C.D., Sutter, N.B., Mellersh, C.S., Parker, H.G., and Ostrander, E.A. (2007). A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet., 3.","DOI":"10.1371\/journal.pgen.0030079"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.5455\/OVJ.2024.v14.i12.4","article-title":"A review of myostatin gene mutations: Enhancing meat production and potential in livestock genetic selection","volume":"14","author":"Ayuti","year":"2024","journal-title":"Open Vet. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jvc.2019.08.002","article-title":"Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy","volume":"25","author":"Yang","year":"2019","journal-title":"J. Vet. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1532-5415.2001.49214.x","article-title":"Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women\u2019s Health and Aging Study II cohort","volume":"49","author":"Seibert","year":"2001","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/JOE-07-0596","article-title":"Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway","volume":"197","author":"Wang","year":"2008","journal-title":"J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jcp.24298","article-title":"IGF-1 induces IP3-dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation","volume":"228","author":"Valdes","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2014-1271","article-title":"Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer","volume":"99","author":"Padhi","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: A proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s11010-024-05120-y","article-title":"Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions","volume":"480","author":"Wetzlich","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000356740","article-title":"Myostatin and sarcopenia: Opportunities and challenges\u2014A mini-review","volume":"60","author":"White","year":"2014","journal-title":"Gerontology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","article-title":"Mechanisms of muscle wasting in chronic kidney disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1159\/000489911","article-title":"Serum Fas Ligand, Serum Myostatin and Urine TGF-\u03b21 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function","volume":"43","author":"Raptis","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yano, S., Nagai, A., Isomura, M., Yamasaki, M., Kijima, T., Takeda, M., Hamano, T., and Nabika, T. (2015). Relationship between Blood Myostatin Levels and Kidney Function: Shimane CoHRE Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141035"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/ndt\/gfq159","article-title":"Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?","volume":"25","author":"Yilmaz","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","unstructured":"International Renal Interest Society (2024, January 03). IRIS Staging of CKD. Available online: https:\/\/www.iris-kidney.com\/iris-guidelines-1."},{"key":"ref_31","unstructured":"WSAVA Global Nutrition Committee (2024, January 03). Body Condition Score. Available online: https:\/\/wsava.org\/wp-content\/uploads\/2020\/01\/Cat-Body-Condition-Scoring-2017.pdf."},{"key":"ref_32","unstructured":"WSAVA Global Nutrition Committee (2024, January 03). Muscle Condition Score. Available online: https:\/\/wsava.org\/wp-content\/uploads\/2020\/01\/Muscle-Condition-Score-Chart-for-Cats.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation","volume":"44","author":"Wright","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.2460\/javma.22.07.0323","article-title":"Serum myostatin decreases in exercising and aging Alaskan sled dogs, while growth and differentiation factor 15 remains unaltered","volume":"260","author":"Shiomitsu","year":"2022","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"32084","DOI":"10.1038\/srep32084","article-title":"Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1","volume":"6","author":"Enoki","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ki.2010.494","article-title":"Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease","volume":"79","author":"Verzola","year":"2011","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI117208","article-title":"Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes","volume":"93","author":"Mitch","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.jrn.2006.04.028","article-title":"Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients","volume":"16","author":"Kopple","year":"2006","journal-title":"J. Ren. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ndt\/gfac136","article-title":"Mechanisms of myostatin and activin A accumulation in chronic kidney disease","volume":"37","author":"Bataille","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7635459","DOI":"10.1155\/2017\/7635459","article-title":"Modulation of Myostatin\/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities","volume":"2017","author":"Esposito","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4103\/1319-2442.239648","article-title":"Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients","volume":"29","author":"Koyun","year":"2018","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Esposito, P., Battaglia, Y., La Porta, E., Grignano, M.A., Caramella, E., Avella, A., Peressini, S., Sessa, N., Albertini, R., and Di Natali, G. (2019). Significance of serum Myostatin in hemodialysis patients. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1647-9"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.eurger.2015.11.002","article-title":"Critical analytical evaluation of promising markers for sarcopenia","volume":"7","author":"Cavalier","year":"2016","journal-title":"Eur. Geriatr. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2265.2011.04120.x","article-title":"Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis","volume":"75","author":"Han","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1152\/japplphysiol.00874.2015","article-title":"Paracrine and endocrine modes of myostatin action","volume":"120","author":"Lee","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.jrn.2018.11.010","article-title":"Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis","volume":"29","author":"Delanaye","year":"2019","journal-title":"J. Ren. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lee, S.M., Han, M.Y., Kim, S.H., Cha, R.H., Kang, S.H., Kim, J.C., and An, W.S. (2022). Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study. Toxins, 14.","DOI":"10.3390\/toxins14100660"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Avin, K.G., Chen, N.X., Organ, J.M., Zarse, C., O\u2019Neill, K., Conway, R.G., Konrad, R.J., Bacallao, R.L., Allen, M.R., and Moe, S.M. (2016). Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159411"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1113\/jphysiol.2009.172544","article-title":"Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling","volume":"587","author":"Rodgers","year":"2009","journal-title":"J. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2460\/javma.234.11.1398","article-title":"Prevalence of cardiomyopathy in apparently healthy cats","volume":"234","author":"Paige","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"106207","DOI":"10.1016\/j.tvjl.2024.106207","article-title":"Myostatin serum levels depends on age and diet in athletic and no athletic dogs","volume":"307","author":"Bendig","year":"2024","journal-title":"Vet. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1038\/s41598-020-62875-2","article-title":"Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy","volume":"10","author":"Verzola","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chang, H.H., Wang, C.H., Lin, Y.L., Kuo, C.H., Liou, H.H., and Hsu, B.G. (2024). Relationship Between Serum Myostatin and Endothelial Function in Non-Dialysis Patients with Chronic Kidney Disease. Diseases, 12.","DOI":"10.3390\/diseases12120328"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2460\/javma.1987.190.09.1196","article-title":"Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973\u20131984)","volume":"190","author":"DiBartola","year":"1987","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2460\/javma.1987.191.12.1563","article-title":"Potassium depletion in cats: Hypokalemic polymyopathy","volume":"191","author":"Dow","year":"1987","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1939-1676.1997.tb00093.x","article-title":"Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure","volume":"11","author":"Theisen","year":"1997","journal-title":"J. Vet. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.jrn.2022.01.011","article-title":"The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease","volume":"32","author":"Yasar","year":"2022","journal-title":"J. Ren. Nutr."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/1\/89\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:46:34Z","timestamp":1768484794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/1\/89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["vetsci13010089"],"URL":"https:\/\/doi.org\/10.3390\/vetsci13010089","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}